Panoral en es it fr

Panoral Brand names, Panoral Analogs

Panoral Brand Names Mixture

  • No information avaliable

Panoral Chemical_Formula

C15H14ClN3O4S

Panoral RX_link

http://www.rxlist.com/cgi/generic/cefaclor.htm

Panoral fda sheet

Panoral FDA

Panoral msds (material safety sheet)

Panoral MSDS

Panoral Synthesis Reference

R. R. Chauvette, U.S. Pat. 3,925,372 (1975)

Panoral Molecular Weight

367.808 g/mol

Panoral Melting Point

327 oC

Panoral H2O Solubility

8.6 mg/mL

Panoral State

Solid

Panoral LogP

0.517

Panoral Dosage Forms

Capsule; Powder; Powder for solution; Powder for suspension; Suspension

Panoral Indication

For the treatment of certain infections caused by bacteria such as pneumonia and ear, lung, skin, throat, and urinary tract infections.

Panoral Pharmacology

Cefaclor is a second generation cephalosporin antibiotic with a spectrum resembling first-generation cephalosporins. In vitro tests demonstrate that the bactericidal action of the cephalosporins results from inhibition of cell-wall synthesis. Cefaclor has been shown to be active against most strains of the following microorganisms, both in vitro and in clinical infections: Gram positive aerobes - Staphylococci (including coagulase-positive, coagulase-negative, and penicillinase-producing strains), Streptococcus pneumoniae, and Streptococcus pyogenes (group A ß-hemolytic streptococci). Gram-negative aerobes - Escherichia coli, Haemophilus influenzae (including ß-lactamase-producing ampicillin-resistant strains), Klebsiella sp, and Proteus mirabilis.

Panoral Absorption

Well absorbed after oral administration, independent of food intake.

Panoral side effects and Toxicity

Symptoms of overdose include diarrhea, nausea, stomach upset, and vomiting.

Panoral Patient Information

Patients should be counseled that antibacterial drugs including Ceclor should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Ceclor is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Ceclor or other antibacterial drugs in the future.

Panoral Organisms Affected

Enteric bacteria and other eubacteria